Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

KP Rovers; C Bakkers; G Simkens; JWA Burger; SW Nienhuijs; GJM Creemers; AMJ Thijs; Alexandra Brandt - Kerkhof; Eva Madsen; Ninos Ayez; Nadine de Boer; Esther van Meerten; Kees Verhoef; PJ Tanis; IHJT de Hingh

doi:10.1186/s12885-019-5545-0

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

KP Rovers, C Bakkers, G Simkens, JWA Burger, SW Nienhuijs, GJM Creemers, AMJ Thijs, Alexandra Brandt - Kerkhof, Eva Madsen, Ninos Ayez, Nadine de Boer, Esther van Meerten, Kees Verhoef, PJ Tanis, IHJT de Hingh

Research output: Contribution to journal › Article › Academic › peer-review

93 Citations (Scopus)

33 Downloads (Pure)

Original language	Undefined/Unknown
Article number	390
Journal	BMC Cancer
Volume	19
DOIs	https://doi.org/10.1186/s12885-019-5545-0
Publication status	Published - 2019

Research programs

EMC MM-03-47-11
EMC MM-03-86-08

Access to Document

10.1186/s12885-019-5545-0

Repub_117031_O-A.pdfFinal published version, 1.18 MB

http://hdl.handle.net/1765/117031

Cite this

Rovers, KP., Bakkers, C., Simkens, G., Burger, JWA., Nienhuijs, SW., Creemers, GJM., Thijs, AMJ., Brandt - Kerkhof, A., Madsen, E., Ayez, N., de Boer, N., van Meerten, E., Verhoef, K., Tanis, PJ., & de Hingh, IHJT. (2019). Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6). BMC Cancer, 19, Article 390. https://doi.org/10.1186/s12885-019-5545-0

@article{8ca2ca1c812d4469b86dd4b884f0ec41,

title = "Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)",

author = "KP Rovers and C Bakkers and G Simkens and JWA Burger and SW Nienhuijs and GJM Creemers and AMJ Thijs and {Brandt - Kerkhof}, Alexandra and Eva Madsen and Ninos Ayez and {de Boer}, Nadine and {van Meerten}, Esther and Kees Verhoef and PJ Tanis and {de Hingh}, IHJT",

year = "2019",

doi = "10.1186/s12885-019-5545-0",

language = "Undefined/Unknown",

volume = "19",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

}

Rovers, KP, Bakkers, C, Simkens, G, Burger, JWA, Nienhuijs, SW, Creemers, GJM, Thijs, AMJ, Brandt - Kerkhof, A , Madsen, E, Ayez, N, de Boer, N, van Meerten, E , Verhoef, K, Tanis, PJ & de Hingh, IHJT 2019, 'Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)', BMC Cancer, vol. 19, 390. https://doi.org/10.1186/s12885-019-5545-0

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6). / Rovers, KP; Bakkers, C; Simkens, G et al.
In: BMC Cancer, Vol. 19, 390, 2019.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

AU - Rovers, KP

AU - Bakkers, C

AU - Simkens, G

AU - Burger, JWA

AU - Nienhuijs, SW

AU - Creemers, GJM

AU - Thijs, AMJ

AU - Brandt - Kerkhof, Alexandra

AU - Madsen, Eva

AU - Ayez, Ninos

AU - de Boer, Nadine

AU - van Meerten, Esther

AU - Verhoef, Kees

AU - Tanis, PJ

AU - de Hingh, IHJT

PY - 2019

Y1 - 2019

U2 - 10.1186/s12885-019-5545-0

DO - 10.1186/s12885-019-5545-0

M3 - Article

C2 - 31023318

SN - 1471-2407

VL - 19

JO - BMC Cancer

JF - BMC Cancer

M1 - 390

ER -

Rovers KP, Bakkers C, Simkens G, Burger JWA, Nienhuijs SW, Creemers GJM et al. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6). BMC Cancer. 2019;19:390. doi: 10.1186/s12885-019-5545-0